Julie Walters named Outstanding Female Entrepreneur at Tech Industry Awards 2017

Julie Walters named Outstanding Female Entrepreneur at Tech Industry Awards 2017

London, UK – June 15, 2017. Raremark founder, Julie Walters, won the award for Outstanding Female Entrepreneur at the Enterprise Awards, in London last night.

The awards celebrate some of the most successful technology entrepreneurs in the UK & Ireland and are known as “the Oscars for Technology Entrepreneurs”.

Julie is the driving force behind Raremark, which was founded in January 2016 with a goal to transform one million lives in rare disease.

Julie said: “The patient-led revolution in health is just beginning, particularly in neglected areas of health such as rare disease. This award is a great tribute to our amazing team in being a key part of that digital revolution in health.”

John O’Connell, Chairman of the Scaleup Group and founder of the Enterprise Awards, said: “Entrepreneurship is key to the success of the UK economy, and we continue to be encouraged and impressed by the standard of leaders in this country through the Enterprise Awards.”

About the awards

The Enterprise Awards has the continued support of the Worshipful Company of Information Technologists – and has once again attracted some big name sponsors for the event including Sage, NatWest, Questers, RandDTax, Scaleup Group, Silverpeak, Smith & Williamson, TechMarketView and Stifel. Additional partners for the event include tx2events, FieldHouse Associates and Whiteoaks.

About Raremark

Raremark’s goal is to transform one million lives in rare disease. Our community managers connect families worldwide with up-to-date scientific information, community insights and research opportunities. Raremark is privately funded and headquartered in London, UK with an office in Boston, US. The company was founded by entrepreneur Julie Walters after seeing first-hand the isolation experienced by families affected by rare disease. Revenues come from patient-led market research, providing anonymized patient data to inform drug development and providing information about research.

Community contact

For patients & families

T +44 (0)20 7034 3216


Partnering contact

Julie Walters

T +44 (0) 20 7034 3216

M +44 (0) 775 362 6967


Media contacts

Pete Chan

T +44 (0) 20 7034 3216

M +44 (0) 775 328 0299